Molecular classification of melanoma using real-time quantitative reverse transcriptase-polymerase chain reaction

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Early detection and characterization of metastatic melanoma are critical for prognosis and management.
• Molecular methods offer enhanced sensitivity for detecting occult lymph node metastases compared to standard histopathology.
• These molecular techniques show potential utility in clinical diagnostics for melanoma.

Purpose of the Study:

• To investigate the utility of gene expression profiling using real-time quantitative reverse transcriptase-polymerase chain reaction ([q]RT-PCR) for melanoma detection.
• To identify specific melanoma-related genes and mutations that can differentiate between melanoma and non-melanoma tissues.
• To explore the diagnostic potential of identified molecular markers for melanoma micrometastasis in lymph nodes.

Main Methods:

• Examined 36 samples (30 melanomas, 4 benign nevi, 2 reactive lymph nodes) using [q]RT-PCR.
• Analyzed the expression of 20 melanoma-related genes involved in cell growth, proliferation, progression, and melanin synthesis.
• Tested for mutations in BRAF and NRAS genes.

Main Results:

• Hierarchical clustering distinguished melanoma from non-melanoma samples based on gene expression patterns.
• Melanoma samples were stratified into two groups based on beta-catenin activation and MAPK/ERK pathway gene expression.
• Mutations in BRAF or NRAS were found in 64% of patients and were mutually exclusive.

Conclusions:

• Real-time [q]RT-PCR with hierarchical clustering can identify expression patterns differentiating melanomas from other tissues.
• MLANA, CD63, and BUB1 were identified as the best discriminators for distinguishing melanoma, benign nevi, and lymph nodes.
• These markers hold diagnostic utility for detecting melanoma micrometastasis in sentinel lymph nodes.